Please use this identifier to cite or link to this item:
|Title:||From the periphery to centre stage: De novo single nucleotide variants play a key role in human genetic disease|
|Citation:||Ku, C.-S., Tan, E.K., Cooper, D.N. (2013). From the periphery to centre stage: De novo single nucleotide variants play a key role in human genetic disease. Journal of Medical Genetics 50 (4) : 203-211. ScholarBank@NUS Repository. https://doi.org/10.1136/jmedgenet-2013-101519|
|Abstract:||Human germline mutations arise anew during meiosis in every generation. Such spontaneously occurring genetic variants are termed de novo mutations. Although the introduction of microarray based approaches led to the discovery of numerous de novo copy number variants underlying a range of human genetic conditions, de novo single nucleotide variants (SNVs) remained refractory to analysis at the whole genome level until the advent of next generation sequencing technologies such as whole genome sequencing and whole exome sequencing. These approaches have recently allowed the estimation of the mutation rate of de novo SNVs and greatly increased our understanding of their contribution to human genetic disease. Indeed, de novo SNVs have been found to underlie various common human neurodevelopmental conditions such as schizophrenia, autism and intellectual disability, as well as sporadic cases of rare Mendelian disorders. In many cases, however, confirmation of the pathogenicity of identified de novo SNVs remains a major challenge.|
|Source Title:||Journal of Medical Genetics|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Aug 7, 2018
WEB OF SCIENCETM
checked on Jul 23, 2018
checked on May 4, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.